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1. INTRODUCTION 
The thyrotropin (TSH) receptor is an important 
but poorly characterised component of the thyroid 
cell surface [l] and in this paper we describe an 
analysis of the receptor using affinity labelling [2]. 
Detergent solubilised porcine and human TSH re- 
ceptors have been partially purified by Sepharose 
-TSH affinity chromatography [3] and then 
covalently crosslinked to 125 I-labelled TSH. Analy- 
sis of the TSH-TSH receptor complexes by so- 
dium dodecylsulphate polyacrylamide gel elec- 
trophoresis (SDS-PAGE) suggests that both 
porcine and human TSH receptors contain a simi- 
lar basic unit of two peptide chains linked by one 
or more disulphide bridges. These basic units bind 
one molecule of TSH and have relative molecular 
masses (M,) of 87 000 in the case of the porcine 
TSH receptor and 100 000 in the case of the 
human TSH receptor. 
2. MATERIALS AND METHODS 
over a period of 25 min. 10 ~1 of 1 M glycine was 
then added and after a further 10 min at room 
temperature, the TSH bound and free HSAB were 
separated on a column of Sephadex G-25 run in 
0.1 M Na2HPO4, pH 7.5. Comparison of the UV 
spectra of HSAB, TSH and HSAB-TSH indicated 
that about 2 molecules of HSAB were incorpo- 
rated into each molecule of TSH. The distribution 
of the two molecules of HSAB between the two 
subunits of TSH was investigated by reacting TSH 
with the Bolton-Hunter reagent [7] which would 
be expected to couple to the same amino groups as 
HSAB. Analysis of TSH labelled in this way on 
SDS-PAGE followed by autoradiography indi- 
cated that both (Y and fi subunits contained similar 
amounts of label. HSAB-TSH was found to have 
a specific activity of about 25 MRC units per mg of 
protein as judged by both receptor and bioassays. 
Labelling of TSH and HSAB-TSH with 1251 (1 
atom per molecule) was carried out using the 
iodogen method followed by chromatography on 
Sephadex G-100 [5]. 
2.1. Preparation of 1251~labelled HSA B- TSH 
TSH was extracted from bovine pituitaries and 
2.2. TSH receptor preparations 
purified by conventional procedures [4,5]. The spe- 
cific activity of the purified hormone was 50-60 
MRC units per mg as judged by receptor assay 
[3,5] and bioassay [6]. N-Hydroxysuccinimidyl-4- 
azidobenzoate (HSAB) (Pierce Chemicals; 10 mM 
in dimethyl sulphoxide) was added (4 x 1 ~1) to 
200 pg of TSH (in 200 ~1 of 150 mM NaCl, 20 mM 
NaHCq, pH 7.7) in the dark at room temperature 
Porcine and human TSH receptors were sol- 
ubilised and purified by Sepharose-TSH affinity 
chromatography [3]. IgG was prepared from nor- 
mal human or Graves’ sera by ammonium sul- 
phate precipitation and gel filtration on Sephacryl 
S-300. The ability of unlabelled TSH or Graves’ 
IgG to inhibit 12*1-labelled TSH or 1251-labelled 
HSAB-TSH binding to affinity purified receptors 
was investigated as described previously [3,5]. 
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2.3. Preparation and analysis of crosslinked 
TSH-TSH receptor complexes 
Affinity purified receptors (200 ~1) were incu- 
bated with or without unlabelled TSH (10 ~1) for 
15 min at room temperature followed by addition 
of t251-labelled HSAB-TSH (200 il) and incuba- 
tion at room temperature for a further 3 h in the 
dark. The mixture was then photolysed by placing 
5 cm from a 40 watt UV light for 20 min. 
Crosslinking with disuccinimidyl suberate (DSS) 
was performed under similar conditions except 
that t251-labelled TSH was used and after 3 h at 
room temperature 4 ~1 of 0.1 M DSS in dimethyl 
sulphoxide was added followed by 4 ~1 of 1 M am- 
monium acetate 15 min later. Crosslinked TSH- 
TSH receptor complexes were precipitated by ad- 
dition of polyethylene glycol (M, = 4000) to a 
final concentration of 25% and suspended in 4% 
SDS. In some cases, 2-mercaptoethanol was added 
to a final concentration of 0.1 M and after heating 
at 90°C for 5 min, iodoacetamide was added to a 
final concentration of 0.15 M. The samples were 
centrifuged (14 000 x g for 20 min) and subjected 
to gradient (5-12s) SDS-PAGE [8] together with 
the following M, markers: P-lactoglobulin 
(18 400), IgG light chain (23 500) TSH (28 300), 
ovalbumin (44 000) IgG heavy chain (50 000), 
bovine serum albumin (67 000), transferrin 
(77 000) phosphorylase B (94 000) /3-galactosidase 
(116 400), myosin (205 000) and thyroglobulin 
(320 000 in SDS). MI values were determined 
using reduced standards for reduced samples and 
non-reduced standards for non-reduced samples. 
After staining (Coomassie Blue) and drying, auto- 
radiography was carried out for 16 h at -70°C 
using Kodak X-OMAT RP X-ray film and 
CRONEX lighting-plus enhancing screens (Du- 
Pont). 
3. RESULTS 
125 I-labelled HSAB-TSH showed similar recep- 
tor binding properties to ‘t251-labelled TSH with 
both unlabelled TSH and Graves’ IgG effectively 
inhibiting the binding of both label preparations to 
affinity purified TSH receptors (fig. 1). 
In preliminary experiments, 125 I-labelled 
HSAB-TSH was incubated with thyroid mem- 
brane preparations or non-purified detergent sol- 
ubilised receptors, photolysed and the complexes 
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Fig.1. Inhibition of t*%labelled TSH binding to affinity 
purified porcine TSH receptors by unlabelled TSH = o 
and Graves’ IgG = q . Inhibition of t*51-labelled 
HSAB-TSH binding by unlabelled TSH = . and 
Graves’ IgG = l . Effect of unlabelled TSH on pre-pho- 
tolysed t*sI-labelled HSAB-TSH binding = a. % Label 
specifically bound in the presence or absence of un- 
labelled TSH or Graves’ IgG = B and Bu respectively. 
In the case of t*51-labelled TSH, 30-358 was bound in 
the absence of unlabelled TSH or Graves’ IgG (total 
binding) and this was reduced to about 5% in the pres- 
ence of 10 mU unlabelled TSH (non-specific binding). 
With t*51-labelled HSAB-TSH total and non-specific 
binding were 20-25% and 5% respectively. 
formed analysed by SDS-PAGE followed by au- 
toradiography. However the autoradiograph back- 
grounds were high and it was difficult to discern 
distinct bands which might have corresponded to 
crosslinked TSH-TSH receptor complexes. In 
subsequent experiments therefore, affinity purified 
receptors were used and with these preparations 
covalent crosslinking of labelled TSH to the recep- 
tor was clearly evident (fig.2). In particular, the 
1251 in the TSH-porcine TSH receptor complexes 
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Fig.2. (A) A comparison of reduced and unreduced 
crosslinked complexes of t*sI-labelled HSAB-TSH and 
porcine TSH receptors. The amounts of unlabelled TSH 
included in the incubations are shown at the top of the 
autoradiograph. (B) A comparison of reduced HSAB or 
DSS crosslinked complexes obtained using porcine and 
human TSH receptors. The data shown are typical of 
several separate experiments (see table 1). 
was associated (in the absence of reducing agent) 
with a band of Mr = 115 000 and a band charac- 
teristic of intact TSH (M, = 28 000). The M, = 
115 000 band was not observed in the following 
control experiments: 
(a) When an excess (10 mu) of unlabelled TSH 
was added to receptor preparations prior to in- 
cubation with 1251-labelled HSAB-TSH and 
photolysis (fig.2). 
(b) When labelled HSAB-TSH was incubated 
with heat inactivated receptors or detergent 
only prior to photolysis. 
(c) When mixtures of 1251-labelled HSAB-TSH 
and receptors were not photolysed prior to 
SDS-PAGE (dark control). 
(d) When t251-labelled TSH was used in place of 
t251-labelled HSAB-TSH. 
Consequently the M, = 115 000 band appeared 
to represent a component of TSH specifically 
bound to a component of the porcine TSH recep- 
tor. 
Reduction of photolysed TSH-porcine TSH re- 
ceptor complexes prior to SDS-PAGE changed 
the distribution of 1251 on the gels. The MI = 
115 000 band was not evident and instead, two la- 
belled components M, = 73 000 (slow) and 59 000 
(fast) (table 1 and tig.2) were observed together 
with bands characteristic of intact TSH and the (Y 
and /3 subunits (M, = 13 600 and 14 700 respec- 
tively) [4]. The M, = 73 000 and 59 000 bands ap- 
peared therefore to be specific components of the 
reduced TSH-TSH receptor complex. 
As an alternative approach to the use of t251-la- 
belled HSAB-TSH, TSH was labelled with 1251 
only, incubated with affinity purified porcine TSIj 
receptors and the complex formed crosslinked with 
the homobifunctional reagent DSS. Analysis of the 
reduced complexes by SDS-PAGE followed by 
autoradiography gave a similar gel pattern to that 
observed with HSAB-TSH. Two 1251-labelled 
bands of M, = 71000 and 57 000 were apparent 
together with bands characteristic of intact TSH 
and TSH subunits (fig.2 and table 1). The forma- 
tion of the M, = 71 000 and 57 000 components 
was completely inhibited by an excess (10 mu) of 
unlabelled TSH. Reduced, non-crosslinked t251-la- 
belled TSH was resolved almost completely into (Y 
and fi subunits on SDS-PAGE (fig.2). Unreduced 
DSS crosslinked complexes were not readily solu- 
ble in 4% SDS even after prolonged heating and 
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Table 1 
Relative molecular mass (M,) values of crosslinked TSH-TSH receptor 
complexes observed on SDS-PAGE 
August 1982 
Species Type of Component of Number of Mean Standard 
of TSH cross- TSH-TSH receptor samples 
receptor linking complex analysed (X%3) 
deviation 
Reduced samples 
Porcine HSAB Fast 
Slow 
Slow-Fast 
14 
Porcine DSS Fast 
Slow 
Slow-Fast 
5 
Human HSAB Fast 
Slow 
Slow-Fast 
4 
Human DSS Fast 
Slow 
Slow-Fast 
3 
59.3 1.7 
73.9 2.0 
14.6 1.2 
57.4 2.3 
70.9 2.7 
13.6 0.8 
64.6 3.2 
78.2 2.4 
13.6 1.2 
62.7 2.5 
75.8 1.0 
13.1 1.6 
Non-reduced samples 
Porcine 
Human 
HSAB 10 115 1.8 
DSS 6 128 1.8 
consequently gel analysis of unreduced samples 
was not possible. 
Parallel experiments to those described for por- 
cine TSH receptors were carried out using affinity 
purified human (Graves’) TSH receptors and 
crosslinking with both HSAB and DSS. Similar re- 
sults were obtained to those with porcine receptors 
except that both reduced and non-reduced bands 
gave somewhat higher Mr values (table 1, fig.2). 
4. DISCUSSION 
Interpretation of these results can be most ap- 
propriately made by first considering the analysis 
of reduced TSH--TSH receptor complexes. In the 
case of crosslinking with HSAB or DSS to human 
or porcine receptors, the TSH-TSH receptor com- 
plex was resolved into 2 bands differing in M, by a 
value (14 000) very close to the Mr of a single TSH 
subunit (table 1). In addition, HSAB-TSH which 
was not covalently linked to the receptor but had 
been subject to crosslinking conditions and re- 
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duced was resolved into a mixture of intact (inter- 
nally crosslinked) molecules and free subunits 
(lig.2). These observations suggest therefore that 
the higher and lower M,. bands represent, respec- 
tively, a component of the TSH receptor linked to 
an intact molecule of TSH and a single TSH sub- 
unit. Based on data with HSAB-TSH, this compo- 
nent of the TSH receptor appears to have an M, of 
45 000 in the case of the porcine thyroid and 
50 000 in the case of the human thyroid (after sub- 
traction of the M, values for intact TSH or a single 
TSH subunit). The values obtained with DSS for 
porcine and human TSH receptors were slightly 
lower being MT = 43 000 and 48 000 respectively 
and the reason for this difference is not clear at 
present. One possibility is that crosslinking with 
DSS resulted in more compact complexes which 
would run faster on SDS-PAGE. 
When unreduced samples of crosslinked TSH- 
TSH receptor complexes were analysed by SDS- 
PAGE, little if any free TSH subunits were evi- 
dent, the gels principally showing intact TSH and 
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TSH-TSH receptor complexes. The apparent in- 
ability of SDS alone to dissociate TSH (which does 
not contain intersubunit disulphide bridges) into 
subunits is consistent with previous studies using 
guanidine hydrochloride [4]. It seemed likely 
therefore that the non-reduced TSH-TSH recep- 
tor complex observed on the gels contained one 
molecule of intact TSH (M, = 28 000) the recep- 
tor component with M, = 45 000 observed in re- 
duced samples and an additional receptor compo- 
nent or TSH molecule. The additional molecule 
must have an additional Mr of 42 000 (to give a 
total of 115 000) suggesting that it is a component 
of the receptor ather than TSH. This M, = 42 000 
component appears to be linked to the Mr = 
45 000 component by one or more disulphide 
bridges. Similarly the human TSH receptor ap- 
pears to contain a slightly larger unit consisting of 
two disulphide linked Mr = 50 000 subunits. 
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